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A convenient and precise mass spectrometric method for measure-
ment of the deamidation rates of glutaminyl and asparaginyl
residues in peptides and proteins has been developed; the rates of
deamidation of 306 asparaginyl sequences in model peptides at pH
7.4, 37.0°C, 0.15 M TriszHCl buffer have been determined; a library
of 913 amide-containing peptides for use by other investigators in
similar studies has been established; and, by means of simulta-
neous deamidation rate measurements of rabbit muscle aldolase
and appropriate model peptides in the same solutions, the use of
this method for quantitative measurement of the relative effects
of primary, secondary, tertiary, and quaternary protein structure
on deamidation rates has been demonstrated. The measured rates
are discussed with respect to the hypothesis that glutaminyl and
asparaginyl residues serve, through deamidation, as molecular
timers of biological events.
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The hypothesis that glutaminyl and asparaginyl residues inpeptides and proteins serve, through deamidative transfor-
mation into glutamyl and aspartyl residues, as molecular timers
of biological events such as protein turnover, development, and
aging (1–4) was originally based on the suggestion and then
experimental proof that the deamidation of cytochrome c occurs
in vivo (5–6) and on reasoning that deamidation is seriously
disruptive to biological systems unless it is being used for
compensating beneficial biological purposes.
Subsequently, it was shown that the first-order deamidation
half times in pH 7.4, 37°C ionic strength 0.15–0.20 phosphate
buffer of glutaminyl and asparaginyl residues vary over a range
of at least 1 day to 9 years as a function of primary sequence and
likely over an even wider range as a function of secondary,
tertiary, and quaternary structure (3, 7–11). The dependence of
deamidation on pH, temperature, ionic strength, and other
solution properties was also demonstrated (3, 12–13). It was
additionally shown that the overall in vivo compositions and
specific sequence distributions of amide residues in peptides and
proteins are supportive of the amide molecular clock hypothesis
(1–3, 14).
The first two specific amide clocks to be identified were those
that control the in vivo turnover rates of cytochrome c (6, 9) and
rabbit muscle aldolase (15–16). Measurements of in vivo turn-
over rates, in vivo steady-state concentrations, in vivo and in vitro
deamidation rates of these proteins, and in vitro deamidation
rates of appropriate model peptides demonstrated both se-
quence dependence and three-dimensional structure depen-
dence of the deamidation of these two proteins. Sequence-
controlled deamidation of the C-terminal sequence . . . Thr-Asn-
Glu in cytochrome c apparently leads to a changed three-
dimensional structure that accelerates a second deamidation of
cytochrome c. The resulting deamidated forms of cytochrome c
are rapidly catabolized in vivo with rates equivalent to the
turnover rate. In the case of rabbit muscle aldolase, sequence-
controlled deamidation of the C-terminal sequence . . . Ileu-Ser-
Asn-His-Ala-Tyr and in vivo turnover proceed at the same rates,
the former apparently timing the latter. In both proteins, com-
parisons to model peptides also showed general suppression of
deamidation of other amides in the proteins by means of
three-dimensional structure effects. Deamidation of histone
peptides was also reported and discussed in terms of develop-
ment and aging (10). Since this initial work, much progress has
been made. See, for example, recent experiments on deamida-
tion of phenylalanine hydroxylase (17), histone (18), crystallin
(19), trisphosphate isomerase (20), and ribonuclease (21).
It has been proposed that the deamidation of asparaginyl
peptides at neutral pHs proceeds by way of a cyclic five-
membered imide formed from the asparaginyl a carbon and side
chain and the peptide bond nitrogen of the next residue toward
the carboxyl end of the peptide (11, 22). This mechanism
explains the production of both aspartyl and isoaspartyl peptides
during deamidation, which has been widely observed.
The general approach that was first taken toward understand-
ing the effects of primary, secondary, tertiary, and quaternary
peptide and protein structure on deamidation was that of
measuring the effects of primary structure in model peptides and
then inferring the effects of secondary, tertiary, and quaternary
structure by comparison with the deamidation rates of peptides
and proteins of interest (2–4, 7–10, 16). Therefore, the deami-
dation rates of about 60 model peptides and several proteins
were determined by means of the labor-intensive techniques
available in the 1970s. Although a substantial amount of exper-
imental data, which is beyond the scope of this discussion, has
subsequently accumulated concerning deamidation, and new
techniques have been used, progress has been impeded by lack
of knowledge of the complete library of sequence-controlled
deamidation rates and by lack of a fast and accurate means of
determining the rates of deamidation of each amide in a protein,
with reference to the model peptide rates.
We have, therefore, synthesized, by means of Merrifield
solid-phase peptide synthesis (23–24), the entire library of 800
possible nearest-neighbor amide sequences in pentapeptides,
which involve the 20 ordinary amino acid residues, and an
additional 113 peptides of interest to the effects of residues
between 2 and 6 positions distant from the amides in up to 13
residue peptides.
We have devised a means of measuring the rates of deami-
dation of these peptides by direct loop injections into an ion-trap
mass spectrometer. This method permits the determination of an
18-point deamidation curve with an inherent deamidation pre-
cision error of less than 1% by means of 18 loop injections
requiring about 2 h total mass spectrometer time. Although we
have also shown that measuring several peptides of differing
molecular weights simultaneously can markedly accelerate these
measurements, we prefer to measure the peptides individually
except where simultaneous multiple measurements have special
value as in work on proteins.
Moreover, we have demonstrated that this method can be used
to measure the deamidation rates of specific amides within a
protein, while the rates of deamidation of the peptides to be
compared with that protein are also simultaneously being mea-
sured within the same solution. The model peptides are included
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with the protein during the rate experiment, and the reaction
mixture is digested with an appropriate proteolytic enzyme
before direct injection into the mass spectrometer. The mass
regions of all of the amide-containing peptides are then simul-
taneously scanned.
We herein report the deamidation rates of 306 asparaginyl
pentapeptides. We also report the deamidation rates of the first
two asparaginyl residues near the C terminus of rabbit muscle
aldolase along with the rates of simultaneously measured anal-
ogous model peptides, which allow the determination of the
effects of primary and secondary structure on these aldolase
deamidations. All of these rates of deamidation were determined
at pH 7.4 in 0.15 M TriszHCl buffer at 37.0°C with peptide and
protein concentrations of 1.0 3 1023 M.
Materials and Methods
Synthesis of Peptides. The peptides were synthesized by means of
Merrifield solid-phase peptide synthesis (23, 24) in an Advanced
ChemTech Model 396 MBS synthesizer with a 96-well reaction
block. Derivatives used were 9-f luorenylmethoxycarbonyl
(Fmoc)-Ala, Fmoc-Arg(2,2,4,6,7-pentamethyldihydrobenzofu-
ran-5-sulfonyl), Fmoc-Asp(O-t-butyl), Fmoc-Asn, Fmoc-
Cys(acetamidomethyl), Fmoc-Glu(O-t-butyl), Fmoc-Gln, Fmoc-
Gly, Fmoc-His(Trityl), Fmoc-Ile, Fmoc-Leu, Fmoc-Lys(t-
butyloxycarbonyl), Fmoc-Met, Fmoc-Phe, Fmoc-Pro, Fmoc-
Ser(t-butyl), Fmoc-Thr(t-butyl), Fmoc-Trp, Fmoc-Tyr(t-butyl),
Fmoc-Val, and Wang resin substituted with 0.67 meqyg Fmoc-
Gly. These were all purchased from Peptides International.
Each well of the synthesizer initially contained 0.1 g of Wang
resin. Double couplings for 45 min each with a 3-min 1.5-ml wash
of 50:50 N-methylpyrrolidone (NMP)ydimethylformamide
(DMF) between couplings were used. Reagents for each cou-
pling were 0.5 ml of 0.5 M derivative in NMP; 0.5 ml of coupling
reagent that was 0.5 M 2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate and 0.5 M 1-hydroxy-
benzotriazole in DMF; 0.25 ml of neutralizer that was 2 M
N,N-diisopropylethylamine in NMP; and 0.25 ml of DMF.
Double deblocking with 1.5 ml of 20% piperidine in DMF was
carried out once for 5 min, followed by a second 15-min
deblocking. Resin and side-chain protecting groups were re-
moved with 1.5 ml of scavenger-containing trif luoroacetic acid
(TFA) solution at room temperature for 2 h. The TFA solution
was TFAyanisoleyethylmethylsulfideyethanedithiol in the pro-
portions 93:3:3:1, respectively, by volume. The product was
filtered and the resin washed once with 1 ml of TFA. Eleven
separate syntheses were performed, with 96 peptides synthesized
simultaneously in most cases.
The peptides were precipitated and washed three times with
15 ml of methyl-t-butyl ether, vacuum dried, dissolved in 18.2
MV distilled and purified H2O, divided into five parts in
low-temperature vials, freeze dried, and stored at 280°C.
The acetamidomethyl-blocking groups of cystine were approx-
imately 20% removed in TFA. Deamidation rates of both the
blocked and unblocked peptides were measured by mass spec-
trometry. Deamidation rates for the blocked peptides will be
reported elsewhere.
Yields were determined by hydrolysis with 6 N HCl in H2O at
95°C for 48 h followed by amino acid analysis in a Thermoquest
HPLC with a P4000 pump, AS3000 autosampler, and UV6000LP
detector combined with a Pickering PCX5200 derivatizer (Pick-
ering Laboratories, Mountain View, CA), column, ninhydrin,
and lithium buffer system. Yields averaged about 70% with the
remaining peptide either not washed from the resin or solubi-
lized during the ether washes. In most cases, impurities in the
peptides were so minimal as to be indistinguishable from back-
ground in the mass spectrometer.
Deamidation of Peptides. Peptide deamidation reactions were
carried out in pH 7.4, 37.0°C, 0.15 M TriszHCl buffer. Peptide
concentrations were 1.0 3 1023 M. These reactions were carried
out in 1.5-ml polypropylene centrifuge vials with screw caps and
rubber O-rings. The vials were also sealed in trays in a hydrated
environment to prevent evaporation. Half of the vials in each
experiment, alternating in reaction times, were fitted with
pressed-in 0.002-inch-thick Teflon film liners and tops. Each vial
contained 100 ml of solution.
The deamidation reactions took place in a specially con-
structed incubation chamber controlled at 37.00 6 0.02°C
throughout the 3-month period of these experiments. This
chamber was continuously monitored by means of three ther-
misters and one glass thermometer; one of the thermisters and
the thermometer were calibrated to ASTM standards.
Incubation times varied between 4 and 102 days. These were
adjusted to provide measured points over a range of at least
one-fourth and at most six deamidation half times for each
individual peptide or protein. At timed intervals, vials were
removed from the incubator and frozen at 280°C. All portions
for an individual rate were measured in a single set of mass
spectrometry runs with the analyses alternated to eliminate drift
errors during the course of the mass spectrometry.
In the case of aldolase, ICN rabbit muscle aldolase precipi-
tated from 6 M ammonium sulfate was centrifuged, dissolved in
H2O, and diluted to 1.0 3 1023 M. The solution also contained
the peptides Gly-Ser-Asn-His-Gly and Gly-Ala-Asn-Ser-Gly at
1.0 3 1023 M and was 0.015 M in pH 7.4 TriszHCl buffer. This
solution was divided into 50-ml portions in polypropylene vials,
placed at 37.0°C, removed from the incubator at 14 1-day
intervals, and frozen at 280°C. Before mass spectrometric
analysis, 3-ml portions of the reaction mixtures were each mixed
with 16 ml of a 0.5 mgyml solution of Sigma T-1426 TPCK
treated trypsin or ICN 100478 a-chymotrypsin respectively. The
trypsin mixtures were incubated at 37.0°C for 2 hours, and the
chymotrypsin mixtures were incubated at 25°C for 10 min before
dilution for mass spectrometry. The tryptic and chymotryptic
digests were injected separately into the mass spectrometer, so
28 loop injections were performed. Trypsin produced the Ala-
Leu-Ala-Asn-Ser-Leu-Cys-Gln-Gly-Lys peptide and chymotryp-
sin the Ileu-Ser-Asn-His-Ala-Tyr peptide.
Measurement of Deamidation by Mass Spectrometry. Measurements
were made in a Thermoquest LCQ mass spectrometer fitted with
a Thermoquest electrospray source, a Thermoquest AS3500
autosampler, and a customized sample delivery system driven by
a Harvard Apparatus PHD2000 syringe pump with 5- and 10-ml
Hamilton glass syringes. The autosampler had a Teflon-coated
needle assembly, a Tefzel valve rotor, and a PEEK valve body.
The LCQ was powered at 240 V by four Exeltech MX1000 power
modules connected to a battery bank serviced by two Lorain
Flotrol A100F25 rectifiers (Lorain Corporation, Lorain, OH).
The 5-ml syringe contained 1.5% acetic acid in acetone, and
the 10-ml syringe contained purified H2O. These were pumped
to give a combined flow of 40 mlyminute of solution that was
0.5% acetic acid and 33% acetone into the electrospray source.
The heated capillary was at 180°C. The solutions were combined,
after sample introduction into the H2O stream, in a U.466
Upchurch PEEK static mixing T (Upchurch Scientific, Oak
Harbor, WA). Each run consisted of a 50-ml loop injection of
sample, which was monitored continuously for 5–7 min by a
sequence of 4 high-resolution zoom scans centered on the
expected chargeymass ratios and one 100–2,000 chargeymass
low-resolution scan. Approximately two zoom scans per micro-
liter of sample were recorded. Meticulous attention was paid to
the materials in contact with the sample, and the hold-up volume
and surface area of the sample delivery system were minimized.
Teflon and Tefzel were used when available.








Before analysis, the samples were diluted 500-fold with H2O
by pipetting of 1.5 ml into 749 ml in the injection vials. In the case
of proteins and larger peptides, H2O was substituted for acetone
in the injection system to avoid precipitation. All solutions
throughout these experiments were handled in Teflon or
polypropylene containers. No glass containers were used except
for the syringe pump syringes. The aldolase samples were diluted
only 50-fold before analysis; 75-ml injections were used; data
were collected for 8 min per sample; and the LCQ automatic gain
control was turned off to avoid suppression of detector sensi-
tivity by the large amounts of proteolytic enzyme and aldolase
fragments in the sample. The larger samples offset the lesser data
collected per peptide, because each of four peptides was being
scanned simultaneously.
A typical 4-h mass spectrometry run consisted of 36 samples,
with 18 from each of 2 peptide rate experiments. These included
peptides of different masses, and the samples were alternated to
mutually wash the sample delivery system. We also carried out
experiments wherein several peptides of differing mass were
simultaneously measured. The throughput of these procedures
can be increased by 10- to 20-fold by such combined measure-
ments andyor by combined peptide syntheses of appropriately
selected peptide sets. Precision, however, is compromised as the
number of peptides rises. As we wished to keep precision error
in these experiments below 1%, we did not combine peptides for
the experiments reported here, except in the case of the protein
experiments.
Calculation of Results. Raw data from all of the sample-containing
zoom scans from each LCQ run were summed, averaged, and
recorded in Microsoft EXCEL tables to give results as shown in
Figs. 1 and 2. The point-by-point values of these curves were then
corrected for baseline noise, adjusted for the naturally occurring
isotopic ratios, and separated into the contributions from the
undeamidated and deamidated peptides, which differ from each
other in that deamidation increases the mass by 1 atomic mass
unit. The rates of deamidation were then calculated and plotted
as first-order rate curves as shown in Fig. 3. These calculations
were performed in MATHCAD 8 PROFESSIONAL (Math Soft, Cam-
bridge, MA) with overlays from MACRO EXPRESS 2000 (Insight
Software Solutions, Bountiful, VT) that permit large numbers of
calculations to be made sequentially and automatically. In the
course of this work, we have measured and calculated about 500
deamidation rates involving 9,000 loop injections and requiring
a total of about 1,000 h of mass spectrometer operation. With the
aid of our computer programs, each 4 h of mass spectrometer
operation requires about 30 min of manual computer manipu-
lations to calculate the results, largely because our programs are
not integrated into the LCQ software.
Results and Discussion. The results are summarized in Tables 1 and
2. The first-order deamidation half times for the 306 asparaginyl
peptides are between 1 day and 455 days with a distribution
function as shown in Fig. 4. Clearly, the side chain of the amino
acid residue on the carboxyl side of the asparaginyl residue has
a larger effect on the deamidation rate than does the residue on
the amino side. The residues on both sides affect the deamida-
tion rate in an ordered way that is explainable from their
structures and the proposed cyclic imide mechanism. Table 1
reports deamidation rates for amide-side Pro, but not for
carboxyl-side Pro. For all 18 peptides with carboxyl-side Pro, our
measurements showed deamidation half times of more than
1,000 days. Because Pro cannot participate in the five-membered
imide ring, this result would be expected. The duration of our
experiments did not, however, allow the careful and precise
measurement of these rates, so the values will be reported later
after they have been investigated more carefully.
The precision error of the values reported in Table 1 is
generally less than 1%. Systematic errors, however, are also
present. In some cases, the amidated and deamidated peptides
were differentially retarded and slightly absorbed in the sample
delivery system. Usually, the more positively charged peptides
were absorbed more strongly, so the undeamidated peptides
were absorbed more extensively than were the deamidated
products. For this reason, we estimate that the absolute values of
these deamidation rates have probable errors of about 5% or
less.
At pH 7.4, these peptides are not homogeneous molecular
species. For example, the pKs of the carboxyl, imidazole, and
amino groups in the peptide Gly-Ser-Asn-His-Gly are 3.1, 6.4,
and 7.8, respectively (25). Therefore, whereas the carboxyl and
imidazole groups are mostly deprotonated at pH 7.4, the amino
group, to a significant extent, is an equilibrium mixture of the
protonated and deprotonated species, which have different but
similar deamidation rates (25). Some of the variability seen in
Table 1 is, therefore, likely to be the result of differences in pK
of the peptides, but most of the variation arises from peptide
sequence.
Fig. 1. Representative averaged zoom scans from direct 50-ml loop injection
of the peptide Gly-Ala-Asn-His-Gly into the LCQ mass spectrometer. Scans are
from the first, sixth, and fifteenth points of the deamidation experiment.
Deamidation solutions were 1.0 3 1023 M peptide, 0.15 M TriszHCl, pH 7.4, and
37.0°C. Injected solution was 2 3 1026 M peptide and 3 3 1024 M TriszHCl
buffer. The graphs shown are actual and typical unsmoothed experimental
data. The graphical base lines have been omitted to show the quality of these
results.
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We have chosen TriszHCl buffer for these experiments, be-
cause it is relatively benign in its direct effects on deamidation
rate as compared, for example, to phosphate (3, 12). As these
studies are expanded, the TriszHCl rates will serve as a base to
which the effects of other solute molecules can be added. Of
central importance, however, is the comparison of peptide
deamidation rates with those of proteins with corresponding
sequences under identical solvent and environmental conditions.
For this reason, the results reported in Table 2 are of special
importance.
Table 2 shows that, as expected from previous work (15–16),
the C-terminal Ser-Asn-His sequence in aldolase deamidates at
essentially the same rate as does its corresponding model pep-
tide—which was present in the same solution at the same time
and was simultaneously measured in the mass spectrometer. The
TriszHCl value of 8.3 days for the deamidation of Gly-Ser-Asn-
His-Gly, as compared with that for aldolase of 9.4 days, is in good
agreement with that previously reported of 6.4 days for Gly-Ser-
Asn-His-Gly in phosphate buffer (16) and aldolase of 8 days (15).
Phosphate buffer is known to accelerate deamidation (12). It is
also in good agreement with the reported in vivo turnover rate
for rabbit muscle aldolase of 8 days (15).
Conversely, however, the second amide sequence from the
C-terminal, Ala-Asn-Ser, deamidated with a half life of 11.4 days
in the peptide but was not observed to deamidate at all in the
protein during the 14-day duration of the experiment. In the
protein, therefore, this sequence has a deamidation rate at least
10- to 20-fold slower than the model. This difference is likely
because this amide is located in an a helix in the protein. The
postulated cyclic imide intermediate involved in the deamidation
of these asparaginyl peptides requires that the amide nitrogen of
the residue toward the carboxyl end of the asparaginyl residue be
available for imide formation. This would require disruption of
the a helix in which this nitrogen is participating.
We suggest that strategically located asparaginyl residues
may serve as useful quantitative detectors of helix formation
in model peptide and other systems. This deamidation rate is
very sensitive to helix and is easily measurable. Helix depen-
dence of deamidation has also been reported in several model
peptides (25).
We are convinced that this method for deamidation rate
measurement of particular sequences in proteins, which we
have demonstrated here with these two sequences in aldolase,
will prove robust. Preliminary experiments that we have
performed with several other proteins have shown that the
majority of their amide-containing peptides are immediately
measurable. Where disulfide bonds are present, it is helpful to
include 1 ml of 0.1 M 1,4-dithiothreitol in the enzymatic
digestion mixtures. Chromatographic and electrophoretic sep-
arations should be avoided entirely because they are time
consuming and because they introduce the possibility of large
systematic errors from differential losses of the amidated and
deamidated peptides during measurement.
Studies of a wide variety of model peptides have shown that
pentapeptide models of the sort summarized in Table 1 are good
surrogates for longer peptides and proteins of similar sequences,
with respect to primary structure effects on deamidation (25). It
is evident that the deamidation rates of these asparaginyl pen-
tapeptides at 37.0°C in pH 7.4, 0.15 M TriszHCl buffer depend
primarily on the adjacent carboxyl-side residue, as would be
expected from the cyclic imide model.
For carboxyl-side residues without specific functionality, the
order of deamidation rates is Gly, Ala, Leu, Val, and Ileu,
Fig. 2. Unsmoothed and uncorrected experimental data for averaged zoom
scans of the sixth deamidation point in the deamidation of Gly-Ala-Asn-His-
Gly. This graph is typical of actual experimental data obtained for the 306
peptides in these experiments.
Fig. 3. First-order rate plot of the deamidation of the peptide Gly-Ala-Asn-
His-Gly. Deamidation half time for the 1.0 3 1023 M peptide in 0.15 M TriszHCl,
at pH 7.4, and 37.0°C was calculated to be 9.3 days, and the first-order rate
constant k 5 0.86 3 1026zsec21.








entirely as expected from steric hindrance. Phe, Tyr, and Trp are
between Ala and Leu and likely also contribute primarily steric
effects. The series Ser, Thr, Cys, and Met follows the order of the
dipole moments of the functional groups, which are geometri-
cally available to stabilize imide formation as is the imidazole
group of His. The Asp side chain is short enough for it, too, to
contribute significantly to deamidation, but the longer Glu, Lys,
and Arg side chains are inhibited by their length.
The amino side residues are also listed in Table 1 in order of
their deamidation-enhancing effect. Although a smaller effect,
this is easily distinguishable. This listing is approximately in the
order of number of peptide rates above and below the medians,
with allowances made for special structures. The order found is
qualitatively similar to that of the carboxyl side.
Some special effects are notable. For example, peptides with
paired nearest-neighboring basic and acidic residues, Glu-Asn-
Lys, Glu-Asn-Arg, Asp-Asn-Lys, and Asp-Asn-Arg, clearly stand
out as having deamidation half times about 50% higher than the
similar singular Glu, Asp, Lys, and Arg analogues. In contrast,
this same effect can be distinguished for Lys-Asn-Glu, Arg-Asn-
Glu, Lys-Asn-Asp, and Arg-Asn-Asp, but it raises deamidation
half times in these peptides only by about 10%. Detailed
discussion and mechanistic considerations of the deamidation
rates reported in Table 1 is beyond the scope of this report and
will be discussed elsewhere.
The deamidation rates in Table 1 serve as a basis for the design
of model peptides appropriate for the separation of primary,
secondary, tertiary, and quaternary structure effects in experi-
ments on proteins. Used in combination with the protein de-
amidation measurement technique exemplified in Table 2, they
are suitable for the evaluation of nearest-neighbor sequence
effects. Effects have also been observed from functional groups
farther removed from Asn and from chain elongation (25). We
are now maintaining a supply of the 800 possible Gly-Xxx-Asn-
Yyy-Gly and Gly-Xxx-Gln-Yyy-Gly peptides and 113 other
amide-containing peptides in our laboratory and are interested
in making them available without cost to investigators wishing to
make use of these peptide models in the comparative evaluation
of deamidation of specific proteins.
Conclusions
The values reported in Table 1 strengthen the hypothesis that
deamidations of peptide and protein amides serve as ubiquitous
Fig. 4. Distribution function of deamidation half times for the 306 aspar-
aginyl pentapeptides of the type Gly-Xxx-Asn-Yyy-Gly listed in Table 1. Half
times are for 1.0 3 1023 M peptide in 0.15 M TriszHCl, pH 7.4, and 37.0°C.
Table 2. Deamidation of rabbit muscle aldolase and model
peptides in 1.0 3 1023 M peptide or protein, 0.15 M
TriszHCl, pH 7.4, and 37.0°C in the same solution
Peptide t1/2 days k 3 106 sec21
Aldolase–IleuSerAsnHisAlaTyr 9.4 0.85
GlySerAsnHisGly 8.3 0.97
Aldolase–AlaLeuAlaAsnSerLeuCysGlnGlyLys More than 150 days
GlyAlaAsnSerGly 11.4 0.70
Table 1. First-order deamidation half times of pentapeptides GlyXxxAsnYyyGly in days at pH 7.4, 37.0°C, 0.15 M TriszHCl
Yyy
Gly His Ser Ala Asp Thr Cys Lys Met Glu Arg Phe Tyr Trp Leu Val Ile Mean Median
Xxx
Gly 1.03 9.2 11.8 21.1 28.0 39.8 40.6 48.2 50.4 73.9 57.8 64.0 63.6 77.1 104 224 287 70.6 50.4
Ser 0.96 8.3 15.1 24.1 30.3 45.7 60.2 55.5 54.9 59.7 59.7 52.2 64.7 76.8 110 233 285 72.7 55.5
Thr 1.04 9.6 17.1 24.6 27.9 50.0 55.5 57.6 47.6 60.8 51.2 76.4 80.6 72.5 110 237 279 74.0 55.5
Cys 1.14 10.8 19.0 26.4 30.6 48.7 46.0 46.6 64.5 48.3 83.1 73.9 83.9 111 119 229 304 79.1 48.7
Met 1.04 10.2 15.2 22.1 26.4 43.6 49.6 60.4 56.9 72.4 58.8 61.9 74.0 92.7 113 211 275 73.2 58.8
Phe 1.15 10.2 18.1 24.2 27.4 39.0 46.5 58.2 58.6 62.4 61.2 69.5 75.1 102 118 203 287 74.2 58.6
Tyr 1.49 10.2 11.9 24.3 28.4 38.1 48.6 55.1 64.3 41.0 56.9 58.0 70.6 120 118 241 306 76.1 55.1
Asp 1.53 9.7 17.0 24.0 29.4 52.4 54.1 75.9 57.3 46.8 87.2 70.1 70.4 80.3 111 241 298 78.0 57.3
Glu 1.45 9.0 16.4 25.8 32.0 36.8 44.2 77.8 59.6 60.3 80.9 70.2 94.5 98.4 130 268 279 81.4 60.3
His 1.14 10.7 15.7 24.6 31.2 47.2 43.9 50.2 63.1 69.4 48.9 72.1 82.3 95.4 116 247 327 79.2 50.2
Lys 1.02 10.5 15.6 23.6 34.0 58.1 49.0 53.5 60.9 72.5 57.4 70.1 96.7 98.1 119 246 313 81.1 58.1
Arg 1.00 10.0 14.3 24.4 34.7 50.7 50.5 49.6 74.4 68.3 67.4 68.3 90.0 127 128 247 311 83.4 67.4
Ala 1.05 9.3 14.9 22.5 31.9 43.5 63.7 55.9 59.2 74.1 62.4 65.6 73.9 130 124 254 300 81.5 62.4
Leu 1.08 10.7 16.7 25.1 32.1 46.1 53.5 60.1 62.6 56.7 62.1 72.4 75.7 74.5 155 294 391 87.6 60.1
Val 1.23 10.2 18.2 27.5 33.5 49.9 63.2 63.8 65.7 64.8 67.4 66.6 79.2 88.9 154 291 366 88.9 64.8
Ile 1.26 11.5 14.5 25.9 33.8 46.3 52.7 64.4 58.8 58.6 66.4 61.5 79.3 86.7 154 295 384 87.9 58.8
Trp 1.75 11.3 15.5 30.7 43.6 38.9 83.1 59.4 64.2 75.7 73.9 71.1 92.6 135 133 226 286 84.8 71.1
Pro 1.18 12.8 18.9 31.8 48.6 63.1 60.0 67.8 78.4 92.0 72.9 100 114 122 181 364 455 111 72.9
Mean 1.20 10.2 15.9 25.1 32.4 46.5 53.6 58.9 61.2 64.3 65.3 69.1 81.2 99 128 253 318 81.4 61.2
SD 0.05 0.25 0.50 0.65 1.4 1.7 2.4 2.1 1.8 2.9 2.6 2.4 3.1 5.0 5.0 9.3 11.9 3.1 2.4
%SD 4.5 2.4 3.2 2.6 4.2 3.6 4.5 3.6 2.9 4.6 4.0 3.4 3.8 5.0 3.9 3.7 3.7 3.7 3.7
Median 1.14 10.2 15.7 24.5 31.6 46.2 51.6 57.9 60.3 63.6 62.3 69.8 79.3 97 119 243 302 78.5 60.3
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and versatile clocks for the timing of biological events. A
necessary condition of this hypothesis is that amide clocks be
available that are suitable for the timing of events throughout the
useful range of biological processes. Although the evidence for
this was good (3) on the basis of the approximately 30 asparaginyl
peptides and 30 glutaminyl peptides previously synthesized and
measured, it is far more robust now that a complete set of
nearest-neighbor rates is becoming available. Fig. 4 shows that an
abundance of nearest-neighbor asparaginyl sequences are avail-
able between deamidation half times of 1 day and 1 year.
Glutaminyl sequences extend this range to more than 10
years (3).
Therefore, near-neighbor variations in combination with se-
quence effects of residues farther away in the peptide chain (25)
and three-dimensional effects from secondary, tertiary, and
quaternary structure surely provide a versatile set of deamida-
tion rates suitable to the durations of most biological processes.
There is an additional possibility regarding protein alteration
and turnover. Amides may serve as molecular indicators that the
integrity of each protein molecule has been maintained. Because
deamidation rates are suppressed by three-dimensional struc-
tures that impede the deamidation reaction, amides contained in
these structures may serve as indicators that the structures are
still intact. If an individual molecule is altered, deamidation
within the altered region may then set off catabolism of that
molecule or some other corrective process, or the altered region
may deamidate to form a peptide or protein with a new function.
It is likely that the lifetime of a set of protein molecules is
determined at the time of synthesis, perhaps through deamida-
tion, as a useful compromise between the time it is expected to
remain intact and useful to the organism and the effort that will
be required to resynthesize it. For some proteins, of course, the
time will be adjusted to remove the protein after it has completed
its work because its continued existence would be harmful.
Molecular clocks are needed, rather than molecule-by-molecule
evaluation of proteins within the living system, because the wide
variety of forms arising as the molecules age would be so great
as to overwhelm even the versatility of a well-developed immune
system. In addition to preprogrammed obsolescence, however,
the possibility that amide evaluators in specific regions of each
molecule may be keeping watch over the integrity of their regions
should be considered.
Moreover, in some cases, deamidated peptides and proteins
may have special biological functions wherein timed deamida-
tion controls their delivery to the biological system. In these
instances, which could control ordinary homeostatic functions or
those related to timed processes such as development or aging,
deamidation would serve as a functional molecular clock rather
than a terminal marking clock.
Only a few biological events have been definitively shown to
be regulated by amide molecular clocks. This is not surprising,
because such demonstrations have, so far, required laborious and
sophisticated experimentation. The original reasoning from
which this hypothesis arose about 30 years ago (1–4) remains
intact and is as follows.
The static properties of asparaginyl and glutaminyl residues
are not unique and can be easily duplicated by some of the other
18 commonly occurring amino acid residues or others that might
be used. The disruptive effect on peptide and protein structure
from deamidation reactions, which introduce postsynthetic
charged residues, is so great that, were they not especially useful,
these amide residues would not be widely present in peptides and
proteins. Therefore, it is likely that the instability of asparaginyl
and glutaminyl residues is their primary biological function, and
that they serve as easily programmable molecular clocks for the
timing of biological processes (1–4).
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